Health Condition 1: E782- Mixed hyperlipidemia
Conditions
Interventions
Intervention1: nil: nil
Sponsors
Nil
Eligibility
Inclusion criteria
Inclusion criteria: diagnosed cases of dyslipidemia on atorvastatin or rosuvastatin therapy in all doses prescribed by the clinician
Exclusion criteria
Exclusion criteria: patients in whom an additional statin therapy could be detrimental or additive for adverse effects like myopathy and raised liver enzymes were excluded. such categories include:- • Patients with h/o liver disease or hepatic failure. • Pregnant and lactating women. • Patients with h/o serious or hypersensitivity reactions to statins. • Patients with documented h/o coronary artery disease or other atherosclerotic disease. • Patients of familial hypercholesterolemia. • Patients taking other class of hypolipidemic drugs (fibrates, niacin) and taking other cardiac drugs like Verapamil and Amiodarone • Patients taking Immunosupressants, Azole antifungal agents, Protease inhibitors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| changes in glucose metabolism by assessing HbA1c/fasting values in both groupsTimepoint: O 3 6 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in cognitive state by asessing MMSE values in both groupsTimepoint: 0 3 6 months | — |
Countries
India
Contacts
Public ContactDr Shruti Sharma
SNMC, AGRA
Outcome results
None listed